Vol 44, No 6 (2010)

open access

Page views 352
Article views/downloads 580
Get Citation

Connect on Social Media

Connect on Social Media

Interleukin-6 gene –174 C/G and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population

Aleksandra Klimkowicz-Mrowiec1, Paweł Wotkow2, Karolina Spisak1, Aleksandra Maruszak3, Maria Styczyńska3, Maria Barcikowska3, Andrzej Szczudlik1, Agnieszka Słowik1
DOI: 10.1016/S0028-3843(14)60149-3
Neurol Neurochir Pol 2010;44(6):537-541.


Background and purpose

Inflammation plays a prominent role in Alzheimer disease (AD) pathogenesis. Interleukin-6 (IL-6), a pro-inflammatory cytokine, and some genetic variations in the IL-6 gene have been reported to be associated with a risk of AD. However, the results of the conducted studies are equivocal.

Material and methods

We genotyped IL-6 (–174 C/G) and apolipoprotein E gene (APOE) common polymorphisms in a large case-controlled study in a Polish population. We included 361 patients aged ≥ 65 years with AD (mean age 75.8 ± 5.3 years, 232 females [64.3%]) and 200 controls (75.3 ± 7.4 years; 119 females [59.5%]), without any neurological deficit, cognitive complaints or history of neurological diseases. The IL-6 polymorphism was genotyped using TaqMan SNP allelic discrimination by means of an ABI 7900HT (Applied Biosystems, Foster City, CA).


The distribution of the IL-6 (–174 C/G) genotypes was similar to that in the controls (AD: C/C = 15.79%, C/G = 51.25%, G/G = 32.96% vs. controls: C/C = 21.50%, C/G = 45.50%, G/G = 33.0%, p > 0.05). Our study confirms previous reports that APOE 4 is strongly related to the risk of AD (OR = 6.17; 95% CI: 4.01–9.49). APOE status did not affect the distribution of the studied IL-6 polymorphism.


IL-6 (–174 C/G) polymorphism is not a risk factor for late onset AD in a Polish population.

Article available in PDF format

View PDF Download PDF file

Neurologia i Neurochirurgia Polska